Home Medicine Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
Article
Licensed
Unlicensed Requires Authentication

Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review

  • Kyriaki Karavanaki EMAIL logo , Christina Karayianni , Ioannis Vassiliou , Marinella Tzanela , Triantafyllia Sdogou , Kostas Kakleas , Charalambos Tsentidis , Marina Vakaki , Alexandra Soldatou , Dimitra Kallinikou , Maria Kostaki , Stathis Tsitsopoulos and Asteroula Papathanasiou
Published/Copyright: May 22, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 9-10

Abstract

Type 1 diabetes mellitus (T1DM) is characterized by selective autoimmune destruction of pancreatic b-cells, resulting in insulin deficiency. Associated autoimmune disorders, such as celiac disease, autoimmune thyroiditis, and gastritis, can coexist in patients with T1DM. These disorders are characterized by the presence of antibodies against tissue transglutaminase (anti-tTG-IgA), thyroglobulin, and thyroid peroxidase (anti-TG, anti-TPO), as well as antibodies against gastric parietal cells. Children with T1DM may also develop organ-specific multiple autoimmunity, with the coexistence of one or more autoimmune disorders. Furthermore, there is a lot of controversy regarding the role of thyroid autoimmunity in the pathogenesis of thyroid cancer. We present a child with T1DM and multiple autoimmunity including autoimmune Hashimoto’s thyroiditis (HT), who developed thyroid cancer. The literature on the prevalence of associated autoimmunity in children with T1DM and the prevalence, pathogenesis, and timely diagnosis of thyroid cancer among patients with HT is also reviewed.

Keywords: childhood; multiple autoimmunity; thyroid cancer; T1DM
Corresponding author: Kyriaki Karavanaki, MD, Department of Pediatrics, Second University, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece, Phone: +30-210-7726488, Fax: +30-210-777-4383, E-mail:

References

1. Eisenbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986;314:1360–8.10.1056/NEJM198605223142106Search in Google Scholar

2. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, et al. IA-2 autoantibodies complement GAD-65 autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 1997;40:95–9.10.1007/s001250050648Search in Google Scholar

3. De Block C, Van Gaal L, Leeuw I, Belgian diabetes registry. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody positive type 1 (insulin-dependent) diabetic patients. J Clin Endocrinol Metab 1999;84:4062–7.10.1210/jc.84.11.4062Search in Google Scholar

4. Abrams P, Leeuw I, Vertommen J, Belgian diabetes registry. In newonset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Diabetic Med 1996;13:415–9.10.1002/(SICI)1096-9136(199605)13:5<415::AID-DIA96>3.0.CO;2-XSearch in Google Scholar

5. Landin-Olsson M, Karlsson FA, Lernmark AÈ, Sundkvist G, Diabetes Incidence Study in Sweden Group. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the Diabetes Incidence Study in Sweden. Diabetes 1992;41:1022–7.10.2337/diab.41.8.1022Search in Google Scholar

6. Cronin CC, Shanahan F. Insulin-dependent diabetes mellitus and celiac disease. Lancet 1997;349:1096–7.10.1016/S0140-6736(96)09153-2Search in Google Scholar

7. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1317–21.10.1016/S0016-5085(98)70007-1Search in Google Scholar

8. Maclaren NK, Riley WJ. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 1985;8(Suppl):34–8.10.2337/diacare.8.1.S34Search in Google Scholar

9. De Graaff LC, Smit JW, Radder JK. Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Netherlands J Med 2007;65:235–47.Search in Google Scholar

10. Vanderpump MP, Tunbridge WM, Grench JM, Appleton D, Bates D, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55–68.10.1111/j.1365-2265.1995.tb01894.xSearch in Google Scholar

11. Maugendre D, Guilhem I, Karacatsanis C, Poirier JY, Leguerrier AM, et al. Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients. Ann Endocrinol 2000;61:524–30.Search in Google Scholar

12. Kordonouri O, Klinghammer A, Lang EB, Gruters-Keslich A, Grabert M, et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes. Diabetes Care 2002;24: 1346–50.10.2337/diacare.25.8.1346Search in Google Scholar

13. Prina Cerai LM, Weber G, Meschi F, Mora S, Bognetti E, et al. Prevalence of thyroid autoantibodies and thyroid autoimmune disease in diabetic children and adolescents. Diabetes Care 1994;17:782–3.10.2337/diacare.17.7.782Search in Google Scholar

14. Rattarasarn C, Diosdado MA, Ortego J, Leelawattana R, Soonthornpun S, et al. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract 2000;49:107–11.10.1016/S0168-8227(00)00146-7Search in Google Scholar

15. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427–53.10.1677/erc.1.00882Search in Google Scholar

16. Carson HJ, Castelli MJ, Gattuso P. Incidence of neoplasia in Hashimoto’s thyroiditis: a fine needle aspiration study. Diagn Cytopathol 1996;14:38–42.10.1002/(SICI)1097-0339(199602)14:1<38::AID-DC8>3.0.CO;2-RSearch in Google Scholar

17. Scarpa V, Kousta E, Tertipi A, Vakaki M, Fotinou A, et al. Treatment with thyroxine reduces thyroid volume in euthyroid children and adolescents with chronic autoimmune thyroiditis. Horm Res Paediatr 2010;73:61–7.10.1159/000271917Search in Google Scholar

18. Kim TY, Kim WB, Song JY, Rhee YS, Gong G, et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) 2005;63:588–93.10.1111/j.1365-2265.2005.02389.xSearch in Google Scholar

19. Nasr MR, Muchopadhyay S, Zhang S, Katzenstein AL. Absence of the BRAF Mutation in HBME1+ and CK19+ atypical cell clusters in Hashimoto Thyroiditis. Anat Pathol 2009;132:906–12.Search in Google Scholar

20. Sheils OM, O’Leary JJ, Uhlmann V, Lättich K, Sweeney EC. RET/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000;8:185–9.10.1177/106689690000800305Search in Google Scholar

21. Hughes DT, Doherty GM. Central neck dissection for papillary thyroid cancer. Cancer Control 2011;18:83–8.10.1177/107327481101800202Search in Google Scholar

22. Rosario PW, Mineiro AF, Prates BS, Silva LC, Calsolari MR. Postoperative stimulated thyroglobulin \<1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioiodine ablation. Thyroid 2012;22:1140–3.10.1089/thy.2012.0190Search in Google Scholar

23. Karavanaki K, Kakleas K, Paschali E, Kefalas N, Konstantopoulos I, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res Paediatr 2009;71:201–6.10.1159/000201108Search in Google Scholar

24. Nagy KH, Lukacs K, Sipos P, Hermann R, Madacsy L, et al. Type 1 diabetes associated with Hashimoto’s thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations. Pediatr Diabetes 2010;11:579–82.10.1111/j.1399-5448.2010.00676.xSearch in Google Scholar PubMed

25. Jonsdottir B, Andersson C, Carlsson A, Delli A, Forsander G, et al. Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents. Diabetologia 2013;56:1735–42.10.1007/s00125-013-2934-9Search in Google Scholar PubMed

26. Kakleas K, Kostaki M, Critselis E, Karayianni C, Giannaki M, et al. Gastric autoimmunity in children and adolescents with type 1 diabetes: A prospective study. Horm Res Paediatr 2012;77:121–6.10.1159/000336923Search in Google Scholar PubMed

27. De Block CE, De Leeuw IH, Vertommen JJ, Rooman RP, Du Caju MV, et al. Beta-cell, thyroid, gastric, adrenal and celiac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001;126:236–41.10.1046/j.1365-2249.2001.01668.xSearch in Google Scholar PubMed PubMed Central

28. Gilon P, Tappaz M, Remade C. Localization of GAD-like immuno-reactivity in the pancreas and stomach of the rat and mouse. Histochemistry 1991;96:355–65.10.1007/BF00271357Search in Google Scholar PubMed

29. Tsai LH, Taniyama K, Tanaka C. Gamma-Aminobutyric acid stimulates acid secretion from the isolated guinea pig stomach. Am J Physiol 1987;253:G601–6.10.1152/ajpgi.1987.253.5.G601Search in Google Scholar PubMed

30. Esteban M, Baxter AG. Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes. Clin Exp Immunol 2001;126:184–6.10.1046/j.1365-2249.2001.01705.xSearch in Google Scholar PubMed PubMed Central

31. Corrias A, Cassio A, Weber G, Mussa A, Wasniewska M, et al. Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med 2008;162:526–31.10.1001/archpedi.162.6.526Search in Google Scholar PubMed

32. Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Ups J Med Sci 2009;114:214–20.10.3109/03009730903276381Search in Google Scholar PubMed PubMed Central

33. Kaloumenou L, Duntas L, Alevisaki M, Mastorakos G, Mantzou E, et al. Thyroid volume, prevalence of subclinical hypothyroidism and autoimmunity in children and adolescents. Journal of Greek Paediatric Society 2007;70:107–14.Search in Google Scholar

34. Haveman JW, van Tol KM, Rouwe CW, Piers DA, Plukker JT. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol 2003;10:15–20.10.1245/ASO.2003.03.002Search in Google Scholar PubMed

35. McKee RF, Krukowski ZH, Matheson NA. Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis. Br J Surg 1993;80:1303–4.10.1002/bjs.1800801028Search in Google Scholar

36. Rosario PW, de Faria S, Bicalho L, Alves MF, Borges MA, et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 2005;24:1385–9.10.7863/jum.2005.24.10.1385Search in Google Scholar

37. Shi C, Li S, Shi T, Liu B, Ding C, et al. Correlation between thyroid nodule calcification morphology on ultrasound and thyroid carcinoma. J Intern Med Res 2012;40:350–7.10.1177/147323001204000136Search in Google Scholar

38. Ying M, Ahuja AT, Evans R, King W, Metreweli C. Cervical lymphadenopathy: sonographic differentiation between tuberculous nodes and nodal metastases from non-head and neck carcinomas. J Clin Ultrasound 1998;26:383–9.10.1002/(SICI)1097-0096(199810)26:8<383::AID-JCU2>3.0.CO;2-ESearch in Google Scholar

39. Pisello F, Geraci G, Lo Nigro C, Li Volsi F, Modica G, et al. Neck node dissection in thyroid cancer. A review. G Chir 2010;31: 112–8.Search in Google Scholar

40. Malamut G, El Machhour R, Montcuquet N, Martin-Lanneree S, Dusanter-Fourt I, et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010;120:2131–43.10.1172/JCI41344Search in Google Scholar

41. Balkwill G, Mantovani A. Inflammation and cancer: back to Virhow? Lancet 2001;357:539–45.10.1016/S0140-6736(00)04046-0Search in Google Scholar

42. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978–96.10.1016/S0025-6196(12)62641-XSearch in Google Scholar

43. Matesa-Anić D, Matesa N, Dabelić N, Kusić Z. Coexistence of papillary carcinoma and Hashimoto’s thyroiditis. Acta Clin Croat 2009;48:9–12.Search in Google Scholar

44. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005;71:874–8.10.1177/000313480507101018Search in Google Scholar

45. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001;25:632–7.10.1007/s002680020165Search in Google Scholar

46. Guarino V, Castellone MD, Avilla E, Melillo RM. Thyroid cancer and inflammation. Mol Cell Endocrinol 2010;321:94–102.10.1016/j.mce.2009.10.003Search in Google Scholar

47. Lee J, Hasteh F. Oncocytic variant in papillary thyroid carcinoma associated with Hashimoto’s thyroiditis: a case report and review of the literature. Diag Cytopathol 2009;37:600–6.10.1002/dc.21092Search in Google Scholar PubMed

48. Ward LS, Kloos RT. Molecular markers in the diagnosis of thyroid nodules. Arc Bras Endocrinol Metab 2013;57:89–97.10.1590/S0004-27302013000200001Search in Google Scholar

Received: 2013-9-13
Accepted: 2014-4-23
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0370
Keywords for this article
childhood; multiple autoimmunity; thyroid cancer; T1DM

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 12.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0370/html
Scroll to top button